Can This Tiny Biotech Take On Pfizer?

Submitted by admin on September 20, 2022 - 10:19am

Source:

Motley Fool

News Tags:

Headline:

snippet:

Prometheus Biosciences and Pfizer are both developing experimental first-of-their-kind treatments for inflammatory bowel disease.
Inflammatory bowel disease candidates from Pfizer and Prometheus Biosciences are similar, but there are a couple of key differences.
Prometheus Biosciences' stock price could skyrocket this year if its candidate outperforms Pfizer's candidate.

Search form